No abstract
Cardiovasc Drugs Ther. 2026 Mar 10. doi: 10.1007/s10557-026-07869-4. Online ahead of print.
NO ABSTRACT
PMID:42018100 | DOI:10.1007/s10557-026-07869-4
Dexmedetomidine Attenuates Myocardial Ischemia/Reperfusion Injury by Inhibiting DNMT3B-Mediated Hypermethylation of the KLF4 Promoter
Scritto il 22/04/2026